Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.7.2619

Selenium and Vitamin E for Prostate Cancer - Justifications for the SELECT Study  

Ramamoorthy, Venkataraghavan (Department of Dietetics and Nutrition, Robert Stempel College of Public Health and Social Work, Florida International University)
Rubens, Muni (Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work, Florida International University)
Saxena, Anshul (Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health and Social Work, Florida International University)
Shehadeh, Nancy (College of Business, Florida Atlantic University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.7, 2015 , pp. 2619-2627 More about this Journal
Abstract
There are several studies that relate oxidative damage as possible mechanism for many cancers. Many studies have also shown that anti-oxidants like selenium and vitamin E decrease the risk for prostate cancer. The main objective of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) study was to look for the benefits of selenium and vitamin E supplementation on prostate cancer. The study had a large sample size, stringent experimental conditions, very long duration, standardized laboratories for biochemical analyses and other factors that contribute to high external validity. The SELECT study failed to show any significant risk reduction for prostate cancers ascribable to selenium and vitamin E supplementations. Because of these conflicting results, many researchers argue about the methods used, supplementations administered (selenium and vitamin E) and indicators used for assessing levels of supplementations. We reviewed many epidemiological studies, clinical trials, and pre-clinical studies. With corroborative evidences we justify that SELECT study has a sound methodology and rationale. In lieu of the contrary results of the select study, researchers should focus on the probable mechanisms for these contrary findings and continue their search for newer and effective agents for prevention of prostate cancer.
Keywords
Selenium; vitamin E; prostate cancer; SELECT study; oxidative stress; anti-oxidant;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Yoshizawa K, Willett WC, Morris SJ, et al (1998). Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90, 1219-24.   DOI
2 Afanas'ev I (2011). Reactive oxygen species signaling in cancer: comparison with aging. Aging Disease, 2, 219.
3 Algotar AM, Stratton MS, Ahmann F, et al (2013). Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate, 73, 328-35.   DOI
4 Allan CB, Lacourciere GM, Stadtman TC (1999). Responsiveness of selenoproteins to dietary selenium 1, 2. Ann Review Nutrit, 19, 1-16.   DOI
5 Behrens W, Thompson J, Madere R (1982). Distribution of alpha-tocopherol in human plasma lipoproteins. Am J Clin Nutrit, 35, 691-6.
6 Bhagat SS, Ghone RA, Suryakar AN, et al (2011). Lipid peroxidation and antioxidant vitamin status in colorectal cancer patients. Indian J Physiol Pharmacol, 55, 72-6.
7 Bidoli E, Talamini R, Zucchetto A, et al (2009). Dietary vitamins E and C and prostate cancer risk. Acta Oncologica, 48, 890-4.   DOI
8 Brawley OW (2012). Prostate cancer epidemiology in the United States. World J Urol, 30, 195-200.   DOI
9 Brown K, Arthur J (2001). Selenium, selenoproteins and human health: a review. Public Health Nutrit, 4, 593-9.
10 Burton GW (1994). Vitamin E: molecular and biological function. Proceedings Nutrit Soc, 53, 251-62.   DOI
11 Catalona WJ, Smith DS, Ratliff TL, et al (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl J Med, 324, 1156-61.   DOI
12 CDC. 2014. Cancer Prevention and Control [Online]. Available: http://www.cdc.gov/cancer/dcpc/data/men.htm [Accessed October 12 2014].
13 Cheng W-H, Wu RT, Wu M, et al (2012). Targeting werner syndrome protein sensitizes U-2 OS osteosarcoma cells to selenium-induced DNA damage response and necrotic death. Biochem Biophys Res Comm, 420, 24-8.   DOI
14 Deneo-Pellegrini H, De Stefani E, Ronco A, et al (1999). Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer, 80, 591.   DOI
15 Dodig S, Cepelak I (2004). The facts and controversies about selenium. Acta Pharm, 54, 261-76.
16 Ford ES, Sowell A (1999). Serun ${\alpha}$-Tecopherol status in the United States population: findings from the third national health and nutrition examination survey. Am J Epidemiol, 150, 290-300.   DOI
17 Duffield-Lillico A, Dalkin B, Reid M, et al (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU International, 91, 608-12.   DOI
18 Farrell PM, Bieri JG (1975). Megavitamin E supplementation in man. Am J Clin Nutr, 28, 1381-6.
19 Fleshner NE, Kapusta L, Donnelly B, et al (2011). Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol, 29, 2386-90.   DOI
20 Fuchs-Tarlovsky V, Bejarano-Rosales M, Gutierrez-Salmean G, et al (2010). [Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancer]. Nutricion Hospitalaria, 26, 819-26.
21 Gaziano JM, Glynn RJ, Christen WG, et al (2009). Vitamins E and C in the prevention of prostate and total cancer in men: the physicians' health study II randomized controlled trial. JAMA, 301, 52-62.
22 Group HPSC (2002). MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 360, 23.   DOI
23 Gupta-Elera G, Garrett AR, Robison RA, et al (2012). The role of oxidative stress in prostate cancer. Eur J Cancer Prev, 21, 155-62.   DOI
24 Ho E, Beaver LM, Williams DE, et al (2011). Dietary factors and epigenetic regulation for prostate cancer prevention. advances in nutrition: Intern Rev J, 2, 497-510.
25 Hartman TJ, Albanes D, Pietinen P, et al (1998). The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev, 7, 335-40.
26 He K (2011). Trace elements in nails as biomarkers in clinical research. European J Clin Investigat, 41, 98-102.   DOI
27 Heinonen OP, Koss L, Albanes D, et al (1998). Prostate cancer and supplementation with ${\alpha}$-tocopherol and ${\beta}$-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90, 440-6.   DOI
28 Hodge AM, English DR, McCredie MR, et al (2004). Foods, nutrients and prostate cancer. Cancer Causes Control, 15, 11-20.   DOI   ScienceOn
29 Horwitt M (1960). Vitamin E and lipid metabolism in man. Am J Clin Nutrit, 8, 451-61.
30 Ide H, Lu Y, Yu J, et al (2012). Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines. Prostate, 72, 1407-11.   DOI
31 Kheirandish P, Chinegwundoh F (2011). Ethnic differences in prostate cancer. Br J Cancer, 105, 481-5.   DOI
32 Kim J-E, Han M, Hanl K-S, et al (2011). Vitamin E inhibition on platelet procoagulant activity: Involvement of aminophospholipid translocase activity. Thrombosis Res, 127, 435-42.   DOI
33 Kirsh VA, Hayes RB, Mayne ST, et al (2006). Supplemental and dietary vitamin E, ${\beta}$-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst, 98, 245-54.   DOI
34 Laranjinha J, Vieira Ol, Madeira Vt, et al (1995). Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration. Arch Biochem Biophys, 323, 373-81.   DOI
35 Klein E, Thompson I, Lippman S, et al (2000). SELECT: the selenium and Vitamin E Cancer prevention trial: rationale and design. Prostate Cancer Prostatic Diseases, 3, 145-51.   DOI
36 Klein EA, Thompson IM, Tangen CM, et al (2011). Vitamin E and the risk of prostate cancer: the selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 306, 1549-56.   DOI
37 Kristal AR, Darke AK, Morris JS, et al (2014). Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst, 106, djt456.   DOI
38 Lawal A, Kolude B, Adeyemi B, et al (2012). Serum antioxidant vitamins and the risk of oral cancer in patients seen at a tertiary institution in Nigeria. Nigerian J Clin Practice, 15.
39 Lemire M, Philibert A, Fillion M, et al (2012). No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon. Environment Int, 40, 128-36.   DOI
40 Levander OA (1997). Selenium requirements as discussed in the 1996 joint FAO/IAEA/WHO expert consultation on trace elements in human nutrition. Biomed Environment Sci, 10, 214-9.
41 Ling MT, Luk SU, Al-Ejeh F, et al (2012). Tocotrienol as a potential anticancer agent. Carcinogenesis, 33, 233-9.   DOI
42 Liu J-G, Zhao H-J, Liu Y-J, et al (2012). Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elements Med Biology, 26, 255-61.   DOI
43 Meyer F, Galan P, Douville P, et al (2005). Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU. VI. MAX trial. Int J Cancer, 116, 182-6.   DOI
44 Lonn E, Bosch J, Yusuf S, et al (2005). Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 293, 1338-47.   DOI
45 Marshall JR, Tangen CM, Sakr WA, et al (2011). Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res, 4, 1761-9.   DOI
46 McCann SE, Ambrosone CB, Moysich KB, et al (2005). Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutrit Cancer, 53, 33-41.   DOI
47 Miller AB (2012). New data on prostate-cancer mortality after PSA screening. N Engl J Med, 366, 1047-8.   DOI
48 Morris MC, Beckett LA, Scherr PA, et al (1998). Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Dis, 12, 121-6.   DOI
49 Muir C, Nectoux J, Staszewski J (1991). The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncol, 30, 133-40.   DOI
50 Neve J (1991). Methods in determination of selenium states. J Trace Elements Electrolytes Health Disease, 5, 1-17.
51 NIH. 2013. Vitamin E fact sheet for health professionals [Online]. Available: http://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/ [Accessed September 14 2014].
52 Powell IJ, Banerjee M, Sakr W, et al (1999). Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer, 85, 472-7.   DOI
53 Roemeling S, Roobol MJ, Kattan MW, et al (2007). Nomogram use for the prediction of indolent prostate cancer. Cancer, 110, 2218-21.   DOI
54 Redman C, Scott JA, Baines AT, et al (1998). Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Letters, 125, 103-10.   DOI
55 Ripple MO, Hagopian K, Oberley TD, et al (1999). Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxidants Redox Signal, 1, 71-81.   DOI
56 Rodriguez C, Jacobs EJ, Mondul AM, et al (2004). Vitamin E supplements and risk of prostate cancer in US men. Cancer Epidemiology Biomarkers Prev, 13, 378-82.
57 Sakr W, Grignon D, Haas G (1998). Pathology of premalignant lesions and carcinoma of the prostate in African-American men. Sem Urol Oncol, 16, 214-20.
58 Schroder FH, Hugosson J, Roobol MJ, et al (2009). Screening and prostate-cancer mortality in a randomized European study. New Engl J Med, 360, 1320-8.   DOI
59 Schuurman AG, Goldbohm RA, Brants HA, et al (2002). A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control, 13, 573-82.   DOI
60 Shimizu H, Ross R, Bernstein L, et al (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer, 63, 963-6.   DOI
61 Steyerberg E, Roobol M, Kattan M, et al (2007). Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urology, 177, 107-12.   DOI
62 Vatassery G, Krezowski A, Eckfeldt J (1983). Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutrition, 37, 1020-4.
63 Swanson C, Patterson B, Levander O, et al (1991). Human [74Se] selenomethionine metabolism: a kinetic model. Am J Clin Nutrit, 54, 917-26.
64 Thompson Jr IM, Goodman PJ, Tangen CM, et al (2013). Long-term survival of participants in the prostate cancer prevention trial. New Engl J Med, 369, 603-10.   DOI   ScienceOn
65 Torricelli P, Caraglia M, Abbruzzese A, et al (2013). ${\gamma}$-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins. Amino Acids, 44, 45-51.   DOI
66 Venkateswaran V, Klotz LH (2010). Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nature Reviews Urology, 7, 442-53.   DOI
67 Virtamo J, Pietinen P, Huttunen J, et al (2003). Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 290, 476-85.   DOI
68 Vlajinac H, Marinkovic J, Ilic M, et al (1997). Diet and prostate cancer: a case-control study. Eur J Cancer, 33, 101-7.   DOI
69 Vykhovanets EV, Shankar E, Vykhovanets OV, et al (2011). High-fat diet increases NF-${\kappa}B$ signaling in the prostate of reporter mice. Prostate, 71, 147-56.   DOI
70 Weinstein SJ, Wright ME, Lawson KA, et al (2007). Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiology Biomarkers Prev, 16, 1253-9.   DOI
71 Wright ME, Weinstein SJ, Lawson KA, et al (2007). Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 16, 1128-35.   DOI
72 Wen Y, Killalea S, Norris L, et al (1999). Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation. Euro J Clin Investigation, 29, 1027-34.   DOI
73 West DW, Slattery ML, Robison LM, et al (1991). Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control, 2, 85-94.   DOI
74 WHO (2008). World cancer factsheet [Online]. Available: http://gicr.iarc.fr/files/resources/20120906-WorldCancerFactSheet.pdf [Accessed September 7 2014].
75 Wu M, Kang MM, Schoene NW, et al (2010). Selenium compounds activate early barriers of tumorigenesis. J Biological Chemistry, 285, 12055-62.   DOI
76 Wu M, Wu RT, Wang TT, et al (2011). Role for p53 in selenium-induced senescence. J Agricultural Food Chemistry, 59, 11882-7.   DOI
77 Xia S-J, Cui D, Jiang Q (2012). An overview of prostate diseases and their characteristics specific to Asian men. Asian J Andrology, 14, 458.   DOI
78 Xia Y, Hill KE, Burk RF (1989). Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood. J Nutrit, 119, 1318-26.
79 Yang L, Pascal M, Wu XH (2013). Review of selenium and prostate cancer prevention. Asian Pac J Cancer Prev, 14, 2181-4.   DOI   ScienceOn